Medical/Pharmaceuticals

United Imaging Reaffirms Commitment to Cybersecurity by Partnering with Clearwater

HOUSTON, June 24, 2020 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, has again affirmed its strategic commitment to leadership in cybersecurity risk management and cybersecurity protection by partnering with Clearwater, the leading provide...

2020-06-24 20:00 1072

Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2020 Financial Results

HONG KONG, June 24, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release financial results fo...

2020-06-24 19:30 14567

Mayne Pharma Announces FDA Filing Acceptance of New Drug Application for E4/DRSP in the US

ADELAIDE, Australia, June 24, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the New Drug Application (NDA) for E4/DRSP to prevent pregnancy has been accepted for review by the US Food and Drug Administration (FDA). The FDA is expected to complete its review in ...

2020-06-24 12:10 5829

WAT Medical Delivers 650,000 Digital Thermometers to Canadian Customers

VANCOUVER, BC, June 22, 2020 /PRNewswire/ -- WAT Medical received an order for 650,000 digital thermometers from partners inCanada earlier this year. As of June, WAT Medical has finished manufacturing and delivering all of the requested units in a timely manner, while satisfying all of the specif...

2020-06-22 21:00 1243

Amid Turmoil, 2020 Tang Prize Laureates Strive for An Orderly New World

TAIPEI, Taiwan, June 21, 2020 /PRNewswire/ -- The theme of the 2020 Tang Prize, "for a world of virtue," is intended to extol the pursuit of the ultimate goodness taken up by its latest laureates who demonstrated to us the best one can achieve in the fields of environmental sustainability, medica...

2020-06-21 12:30 1493

Reistone Announces First Patient Dosed in a Phase II Global Study of SHR0302 JAK Inhibitor for Alopecia Areata

SHANGHAI, June 18, 2020 /PRNewswire/ -- Reistone Biopharma Company Limited (Reistone), a clinical stage biopharmaceutical company focused on developing novel medicines for autoimmune and inflammatory diseases, today announced dosing of the first patient in their Phase II, global clinical trial (R...

2020-06-19 09:16 1261

Kangpu to Present Two Posters at the 2020 American Association for Cancer Research (AACR) Annual Meeting

SHANGHAI, June 17, 2020 /PRNewswire/ -- Kangpu Biopharmaceuticals, a clinical-stage company focused on the discovery and development of next-generation of immunomodulatory small molecules for the treatments of solid tumors, hematological malignancies, auto-immune diseases as well as inflammatory...

2020-06-17 21:00 1672

Immunexpress Awarded BARDA Contract to Develop SeptiCyte® RAPID for COVID-19 Patient Triage

SEATTLE, June 16, 2020 /PRNewswire/ -- Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, has been awarded a grant from the Biomedical Advanced Research and Development Authority ("BARDA"), part of the Office of the Assistant Secretary ...

2020-06-16 20:00 1065

Epredia and Lunaphore Announce Commercial Agreement for Exclusive Distribution of LabSat® Research

PORTSMOUTH, New Hampshire and LAUSANNE, Switzerland, June 15, 2020 /PRNewswire/ -- Epredia , a global leader in precision cancer diagnostics and tissue diagnostics, and Lunaphore Technologies SA, a Swiss life-sciences company developing innovative next-generation equipment f...

2020-06-15 20:00 1673

I-Mab and ABL Bio to Present Preclinical Data for Joint Bispecific Antibody Program at the 2020 American Association for Cancer Research Virtual Meeting II

SHANGHAI and GAITHERSBURG, Md., June 12, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, will be presenting preclinical data on a newly developed, novel asset TJ...

2020-06-12 20:00 7126

World's first iLDC enabling ADC drug receives IND clearance by the US FDA

SUZHOU, China, June 11, 2020 /PRNewswire/ -- GeneQuantum Healthcare (GQ) has recently received the US IND approval for its in-house developed next generation antibody drug conjugate (ADC) asset, GQ1001. This isthe world's first site-specific ADC produced using the intelligent ligase-dependent co...

2020-06-11 17:10 1186

Sao Thai Duong JSC launches RT-LAMP KIT to Meet Demands for the Widening of Testing After Easing of Lockdown

HANOI, Vietnam, June 10, 2020 /PRNewswire/ -- Governments around the world have achieved various levels of success in using lockdown and social distancing to stop the spread of the Coronavirus within the community and to deal with the COVID-19 pandemic.According epidemiologists, the easing of a l...

2020-06-11 10:01 1733

PharmAbcine execute an agreement with Thermo Fisher for the development and manufacturing of its next-generation immune checkpoint blockade, PMC-309 for Phase I

DAEJEON, South Korea, June 10, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a strategic partnership with Thermo Fisher Scientific for the development and manufacturing of PMC-309, a next-generation immune checkpoint blockade to treat cancer. Under this agreement, PharmA...

2020-06-11 00:00 964

CellResearch Corporation - Source of cGMP Umbilical Cord Lining Stem Cells for COVID-19 Related Investigator Initiated Clinical Trials

SINGAPORE, June 10, 2020 /PRNewswire/ -- CellResearch Corporation (CellResearch), a regenerative medicine biotechnology company, is making its cGMP-grade umbilical cord lining stem cell product, CorLiCyte®, available complimentary to any licensed medical institution that is seeking to initiat...

2020-06-10 21:00 1115

Sichuan University, Oxford University launch joint cancer research center

CHENGDU, China, June 10, 2020 /PRNewswire/ -- The University of Oxford and China's Sichuan University have jointly launched a center to bolster research cooperation on gastrointestinal cancer. Representatives from the two sides signed a contract for the Sichuan University-University of Oxford Hu...

2020-06-10 17:29 983

China Eastern Airlines: 200+ Medical Supply Flights to Europe

SHANGHAI, June 10, 2020 /PRNewswire/ -- At 09:09 AM June 5 local time, a China Eastern Airlines (CEA) "passenger to cargo" flight MU7263 took off fromJinan to Milan fully loaded with over 20 tons of supplies. This is CEA's 22nd flight transporting medical equipment directly fromChina to Italy. ...

2020-06-10 14:39 2399

Collaborating in Innovative Medical R&D to combat the pandemic, Alphamab Oncology and Institut Pasteur Shanghai Announce Partnership to Co-develop COVID-19 Neutralizing Antibody

SUZHOU, China, June 9, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Jiangsu Alphamab"), a wholly-owned subsidiary of the Company, has entered a partnership agreement with Institut Pasteur ofShanghai, Chinese Academy of...

2020-06-10 08:40 5962

Alphamab Oncology and Sanofi Enter Collaboration on KN026 in HER2+ Breast Cancer

SUZHOU, China, June 8, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) a clinical stage biopharmaceutical company focusing on innovative biologics medicine for oncology, and Sanofi (EURONEXT: SAN and NASDAQ: SNY), a global biopharmaceutical leader, announced today that Jiangsu Alpham...

2020-06-09 10:10 5858

Innovent and Roche Enter into A Strategic Collaboration to Discover and Develop Multiple Products including Cellular Therapies and Bispecific Antibodies

SUZHOU, China, June 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announ...

2020-06-09 07:30 1876

Antengene Corporation Appoints Mr. Donald Lung as Chief Financial Officer

SHANGHAI and HONG KONG, June 8, 2020 /PRNewswire/ -- Antengene Corporation (Antengene) today announced its appointment of Mr.Donald Lung as Chief Financial Officer (CFO), effectiveJune 8, 2020. Donald will report directly to Dr.Jay Mei, Chairman and CEO of Antengene.

2020-06-08 20:00 2272
1 ... 205206207208209210211 ... 219